Who We Are

We are risk-takers and problem-solvers

From inception, we have invested in high-risk, high-reward research targets; an approach that in 6 short years has transformed the broader approach in the chronic disease management field. As a Company we only focus on technologies which are currently believed to be beyond today’s scientific development capabilities, and out of reach to today’s scientific community, only through our obsession with the impossible are we fulfilling our responsibility of creating a global difference for our next generation.